A Non-Interventional, Registry Study for Chinese Gastric Cancer Patients With HER2 Status: Clinical and Pathological Characteristics, Treatment Patterns and Clinical Outcomes (EVIDENCE)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Trastuzumab (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms EVIDENCE
- Sponsors Roche
- 06 Jun 2017 Results of an interim analysis (n=95) assessing the effectiveness and safety of Trastuzumab in Chinese patients with metastatic gastric cancer, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 17 May 2017 Planned End Date changed from 1 Dec 2017 to 21 Nov 2017.
- 17 May 2017 Planned primary completion date changed from 1 Dec 2017 to 21 Nov 2017.